Yestle Kim

Yestle Kim currently serves as a Senior Director in Health Economics and Outcomes Research at Madrigal Pharmaceuticals since August 2023. Previously, Yestle held positions at LEO Pharma as Director and Associate Director in Health Economics and Outcomes Research from January 2021 to August 2023. Prior experience includes roles at Rhythm Pharmaceuticals Inc. as Senior Manager in Medical Affairs, Sanofi Genzyme in Global Medical Affairs and Scientific Communications focusing on Rare Diseases, and Pfizer in various capacities within Medical Affairs related to Rare Diseases and Cardiovascular. Yestle Kim holds a Doctor of Pharmacy (PharmD) degree with a minor in Health Sciences from Northeastern University, graduating magna cum laude, and a Master of Science in Pharmaceutical Outcomes & Policy (Applied Pharmacoeconomics) from the University of Florida.